Group 1 - The core point of the announcement is that Cao Xiaochun, a shareholder holding more than 5% of the shares, has repurchased part of her shares and released the pledge on them [1][2]. - The number of shares released from pledge is 2.6 million, which accounts for 5.07% of her total holdings and 0.30% of the company's total share capital [2][3]. - The release of the pledge started on September 26, 2024, and will end on September 26, 2025, with Guotai Junan Securities Co., Ltd. as the pledgee [2][3]. Group 2 - As of the announcement date, the cumulative pledge situation shows that Cao Xiaochun is a controlling shareholder, with a total of 22.6 million pledged shares, which is 8.75% of her holdings and 2.32% of the company's total share capital [3]. - Another shareholder, Ye Xiaoping, holds 177,239,541 shares, representing 20.58% of the total shares, with 132,929,656 shares unpledged, accounting for 75% of his holdings [3]. - Together, Cao Xiaochun and Ye Xiaoping hold a total of 228,553,715 shares, which is 26.54% of the total shares, with 151,675,986 shares unpledged, representing 72.73% of their combined holdings [3].
泰格医药:持股5%以上股东曹晓春260万股股份回购并解除质押